PT Millennium Pharmacon International Tbk (ISX:SDPC) NonCurrent Deferred Revenue: Rp Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ISX:SDPC PT Millennium Pharmacon International Tbk ISX:SDPC
79 GF Score
Price Rp193.00
GF Value Rp171.24
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is PT Millennium Pharmacon International Tbk NonCurrent Deferred Revenue?

PT Millennium Pharmacon International Tbk ISX:SDPC -1.53% 79 NonCurrent Deferred Revenue is Rp Mil as of Jun. 2026. GuruFocus rates ISX:SDPC with a GF Score™ of 79/100 and a GF Value™ of Rp171.24 (Modestly Overvalued). The stock has 6 warning signs investors should review.

Non-Current Deferred Revenue represents the non-current portion of deferred revenue amount as of the balance sheet date. Deferred revenue is a liability related to revenue producing activity for which revenue has not yet been recognized and is not expected be recognized in the next twelve months.

PT Millennium Pharmacon International Tbk's non-current deferred revenue for the quarter that ended in Jun. 2026 was Rp Mil.

PT Millennium Pharmacon International Tbk NonCurrent Deferred Revenue Related Terms

PT Millennium Pharmacon International Tbk NonCurrent Deferred Revenue Historical Data

* Premium members only.

The historical data trend for PT Millennium Pharmacon International Tbk's NonCurrent Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Millennium Pharmacon International Tbk NonCurrent Deferred Revenue Chart

PT Millennium Pharmacon International Tbk Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
NonCurrent Deferred Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

PT Millennium Pharmacon International Tbk Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
NonCurrent Deferred Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -
ISX:SDPC
79GF Score
PT Millennium Pharmacon International Tbk ISX:SDPC
NonCurrent Deferred Revenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a NonCurrent Deferred Revenue of Rp Mil mean?
PT Millennium Pharmacon International Tbk (ISX:SDPC) has a NonCurrent Deferred Revenue of Rp Mil as of Jun. 2026. Deferred revenue is a liability related to revenue producing activity for which revenue has not yet been recognized and is not expected be recognized in the next twelve months. View historical data on PT Millennium Pharmacon International Tbk and its competitors.
Is PT Millennium Pharmacon International Tbk's NonCurrent Deferred Revenue too high?
PT Millennium Pharmacon International Tbk's current NonCurrent Deferred Revenue is Rp Mil. Overall, PT Millennium Pharmacon International Tbk has a GF Score™ of 79/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does PT Millennium Pharmacon International Tbk's NonCurrent Deferred Revenue compare to MCK and COR?
PT Millennium Pharmacon International Tbk's NonCurrent Deferred Revenue of Rp Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good NonCurrent Deferred Revenue for a Medical Distribution company?
A good NonCurrent Deferred Revenue depends on the Medical Distribution industry context. However, NonCurrent Deferred Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high NonCurrent Deferred Revenue mean?
A high NonCurrent Deferred Revenue can signal that a stock is expensive relative to its fundamentals. Deferred revenue is a liability related to revenue producing activity for which revenue has not yet been recognized and is not expected be recognized in the next twelve months. View historical data on PT Millennium Pharmacon International Tbk and its competitors. PT Millennium Pharmacon International Tbk's current NonCurrent Deferred Revenue is Rp Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Millennium Pharmacon International Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Millennium Pharmacon International Tbk (ISX:SDPC) is currently considered Modestly Overvalued. The stock's GF Value™ is Rp171.24, compared to a current price of Rp193.00 — trading 12.7% above its estimated fair value. The current NonCurrent Deferred Revenue is Rp Mil. PT Millennium Pharmacon International Tbk's overall GF Score™ is 79/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is NonCurrent Deferred Revenue calculated?
NonCurrent Deferred Revenue is calculated from a company's financial statements. For PT Millennium Pharmacon International Tbk (ISX:SDPC), the current NonCurrent Deferred Revenue is Rp Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PT Millennium Pharmacon International Tbk (ISX:SDPC) Overvalued in 2026?

Based on GuruFocus' analysis, PT Millennium Pharmacon International Tbk stock appears to be overvalued. The current stock price of Rp193.00 is trading 12.7% above its estimated GF Value™ of Rp171.24. GuruFocus considers PT Millennium Pharmacon International Tbk to be Modestly Overvalued.

Key valuation signals for ISX:SDPC:

  • NonCurrent Deferred Revenue: Rp Mil
  • GF Value™: Rp171.24 vs. price of Rp193.00 (12.7% above fair value)
  • GF Score™: 79/100 with 6 warning signs

No single metric tells the full story. See the ISX:SDPC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

PT Millennium Pharmacon International Tbk Business Description

Address Jl. Sultan Iskandar Muda No 18/Jl. Bungur No. 1, Crown Bungur Arteri Lantai 2-4, Kel. Kebayoran Lama Selatan, Kec. Kebayoran Lama, South Jakarta, Jakarta, IDN, 12240
PT Millennium Pharmacon International Tbk is engaged in distributing medicines, food supplements, and medical disposables. The group's operating segments are Prescription medicine, Non-prescription medicine, Medical Disposables, and others, of which the majority of revenue is derived from the Prescription Medicine segment. The company's geographical segments are Jawa, Sumatra, Kalimantan, Sulawesi, and Bali & Lombok.
79GF Score

Get the complete analysis for ISX:SDPC

NonCurrent Deferred Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp193.00
Price
Rp171.24
GF Value